• OPEN AN ACCOUNT
Indian Indices
Sensex
83,576.24 -604.72
( -0.72%)
Global Indices
Nasdaq
49,277.91 260.82
(0.53%)
Dow Jones
6,942.18 0.25
(0.00%)
Hang Seng
51,918.01 800.75
(1.57%)
Nikkei 225
10,051.56 3.35
(0.03%)
Forex
USD-INR
89.93 -0.23
(-0.25%)
EUR-INR
105.10 -0.46
(-0.44%)
GBP-INR
121.29 -0.65
(-0.53%)
JPY-INR
0.57 0.00
(-0.31%)

EQUITY - MARKET SCREENER

Cipla Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500087
INE059A01026
411.5600262
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CIPLA
22.7
117983.06
EPS(TTM)
Face Value()
Div & Yield %
64.35
2
1.1
 

natural capsules ltd
Natural Capsules reports consolidated net loss of Rs 6.99 crore in the September 2025 quarter
Nov 14,2025
Net Loss of Natural Capsules reported to Rs 6.99 crore in the quarter ended September 2025 as against net loss of Rs 0.61 crore during the previous quarter ended September 2024. Sales rose 11.11% to Rs 45.80 crore in the quarter ended September 2025 as against Rs 41.22 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales45.8041.22 11
OPM %-1.9210.92 -
PBDT-3.412.96 PL
PBT-7.690.62 PL
NP-6.99-0.61 -1046